Work

Treatment With Ledipasvir–Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection

Year: 2016

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Annals of Internal Medicine

DOI: 10.7326/m16-1205

Authors: Massimo Colombo, Alessio Aghemo, Hong Liu, Jie Zhang, Hadas Dvory-Sobol, Robert Hyland, Chohee Yun, Benedetta Massetto, Diana M. Brainard, John G. McHutchison, Marc Bourlière, Markus Peck-Radosavljevic, Michael Manns, Stanislas Pol

Institutions: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Medizinische Hochschule Hannover, Hôpital Cochin, Hôpital Saint Joseph, Gilead Sciences (United States), Medical University of Vienna

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Gilead Sciences

OpenAlex ID: W2554701966

FWCI: 28.17

Cites: 32

Cited by: 180

Related to: 10